Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
-467K
-
Total reported value, excl. options
-
$298M
-
Value change
-
-$2.77M
-
Put/Call ratio
-
0.22
-
Number of buys
-
52
-
Number of sells
-
-34
-
Price
-
$8.72
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q4 2015
115 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q4 2015.
REGULUS THERAPEUTICS INC - COM (RGLS) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
.
Largest 10 shareholders include FMR LLC (7.85M shares), WELLINGTON MANAGEMENT GROUP LLP (4.21M shares), RA CAPITAL MANAGEMENT, LLC (3.48M shares), UBS ASSET MANAGEMENT AMERICAS INC (2.66M shares), Capital World Investors (2.02M shares), Foresite Capital Management II, LLC (1.75M shares), BlackRock Fund Advisors (1.37M shares), VANGUARD GROUP INC (1.1M shares), AXA (908K shares), and GOLDMAN SACHS GROUP INC (746K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.